Times News Network
Text size GoodRx had a strong first quarter but effectively removed 2022 guidance. Pixel / Dreamstime News that a large grocer is no longer accepting GoodRx’s pharmacy discount cards has wrecked the stock. Several analysts are downbeat, except one. GoodRx (ticker: GDRX) on Monday retracted its guidance and said that its second quarter will see … Read More “GoodRx Beat Quartely Estimates. Here’s Why the Stock Is Falling.” »
Text size The deal comes ahead of GlaxoSmithKline’s planned spinoff of its consumer health division in July. AFP via Getty Images GlaxoSmithKline has agreed to buy US rare cancer therapy company Sierra Oncology for $ 1.9 billion in cash, as it looks to boost its portfolio of new specialty medicines. The UK drugmaker will pay … Read More “Sierra Oncology Stock Soars After $ 1.9 Billion Takeover by GSK” »
Text size AFP via Getty Images GlaxoSmithKline has agreed to buy US rare cancer therapy company Sierra Oncology for $ 1.9 billion in cash, as it looks to boost its portfolio of new specialty medicines. The UK drugmaker will pay $ 55 a share to buy San Mateo, California-based Sierra Oncology (ticker: SRRA), Glaxo (GSK) … Read More “Sierra Oncology Stock Soars After $ 1.9 Billion Takeover by GlaxoSmithKline” »
Text size This week was a slow one for dividend increase announcements. Freeze Frames / Dreamstime.com Constellation Brands spirit Murphy Oil were among the small number of companies that declared dividend increases this week. In addition, Laboratory Corp. of America Holdings (ticker: LH) initiated a quarterly dividend of 72 cents a share. Labcorp ‘s portfolio … Read More “Constellation Brands and Murphy Oil Raised Their Dividends This Week” »
